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ABSTRACT
The mechanisms by which digested fat is absorbed and transported in the circulation are well 
documented.  However, it is uncertain whether the molecular species composition of dietary 
fats influences the molecular species composition of meal-derived lipids in blood.  This may be 
important because enzymes that remove meal-derived fatty acids from the circulation exhibit 
differential activities towards individual lipid molecular species. To determine the effect of 
consuming oils with different molecular compositions on the incorporation of 20:5n-3 and 
22:6n-3 into plasma lipid molecular species.  Men and women (18 - 30 years) consumed 
standardised meals containing 20:5n-5 and 22:6n-3 (total 450mg) provided by an oil from 
transgenic Camelina sativa (CSO) or a blended fish oil (BFO) which differed in the 
composition of 20:5n-3 and 22:6n-3 – containing molecular species.  Blood was collected 
during the subsequent 8 hours.  Samples were analysed by liquid chromatography-mass 
spectrometry.  The molecular species composition of the test oils was distinct from the 
composition of plasma triacylglycerol (TG) or phosphatidylcholine (PC) molecular species at 
baseline and at 1.5 or 6 hours after the meal.  The rank order by concentration of both plasma 
PC and TG molecular species at baseline was maintained during the postprandial period.  
20:5n-3 and 22:6n-3 were incorporated preferentially into plasma PC compared to plasma TG.  
Together these findings suggest that the composition of dietary lipids undergoes extensive 
rearrangement after absorption, such that plasma TG and PC maintain their molecular species 
composition, which may facilitate lipase activities in blood and/or influence lipoprotein 
structural stability and function. 
Key words:  Phosphatidylcholine, triacylglycerol, docosahexaenoic acid, eicosapentaenoic 
acid, postprandial, molecular species
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1. Introduction
The mechanisms by which dietary fatty acids are absorbed, enter the blood stream and 
are turned over in the circulation are well described [1,2].  Briefly, dietary triacylglycerol (TG) 
is hydrolysed in the small intestine, primarily by the activity of pancreatic lipase, to yield fatty 
acids, derived from cleavage at the sn-1/3 positions, and sn-2 monoacylglycerol (2-MG) [3] 
which are absorbed from the unstirred water layer interface between the gut lumen and the 
apical surface of enterocytes.  Fatty acids and 2-MG derived from hydrolysed TG are re-
esterified in enterocytes to form primarily TG [4] or phosphatidylcholine (PC) before assembly 
into chylomicrons.  In human enterocytes, between 70% and 90% of TG is synthesised via the 
MG pathway during the postprandial period [5], while the remainder is formed by the glycerol-
3-phosphate pathway [4,6].  Enterocytes synthesise PC by the CDP:phosphocholine 
cytidylyltransferase pathway [7,8] and by re-acylation of biliary lysoPC [7, 8].  PC synthesis is 
required for absorption of digested lipids, and for the assembly and formation and secretion of 
chylomicrons [7,9].  However, the relevance of these experiments in rodents to human 
postprandial lipid metabolism and to understanding the relative contributions of these pathways 
to chylomicron metabolism under physiological conditions is uncertain.   Recent findings show 
that in addition to contributing to chylomicron structure, PC may be an important carrier of 
meal-derived long-chain polyunsaturated fatty acids (PUFA), namely 20:5n-3 and 22:6n-3, 
from enterocytes to the blood stream [11, 12].  One possible implication of these findings is 
that the partitioning of fatty acids between chylomicron TG and PC may be an important 
influence on the composition of fatty acids available to peripheral tissues after a meal.  This 
suggestion is supported by the observation that the fatty acid composition of chylomicron TG 
can influence the uptake of meal-derived fatty acids by peripheral tissues [13].  In this context, 
the molecular specificity of enterocyte TG and PC synthesis may be an important factor in the 
postprandial metabolism of blood lipids.  
The two principal enzymes that hydrolyse esterified fatty acids in blood; lipoprotein 
lipase (LPL) and lecithin-cholesterol acyltransferase (LCAT) exhibit differential activity 
towards TG and PC molecular species, respectively, according to fatty acid chain length, 
unsaturation and the distribution of fatty acids between sn positions on the glycerol moiety of 
TG [14, 15].  LCAT preferentially hydrolyses sn-1 16:0 PC molecular species when paired 
with sn-2 polyunsaturated fatty acids (PUFA) including 20:4n-6 or 22:6n-3 [16].  The fatty 
acid composition and sn position within the glycerol moiety chylomicron TG can influence 
particle size [17] and LPL activity [15, 18-20] which, in turn, can influence rate of clearance of 
meal-derived lipids from the circulation [21, 22].  This may have implications for health as the 
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rate of chylomicron clearance is a risk factor for cardiovascular disease [23].  Thus, it is 
possible that the molecular species composition of chylomicron PC and TG may influence their 
turnover by LPL and LCAT within the circulation, and consequently the uptake of fatty acids 
derived from the meal by peripheral tissues. 
There is limited information about the postprandial incorporation of fatty acids into 
individual lipid molecular species in human blood.  The molecular species composition of 
chylomicron and VLDL TG during the postprandial period from women who consumed palm 
oil or transesterified palm oil suggested that the plasma lipids reflected the molecular species 
of the ingested lipids [24], although the reporting of the fatty acid compositions of individual 
species was incomplete.  Moreover, the findings of a study in which men consumed inter-
esterified fats containing differing amounts of saturated or trans fatty acids, or 18:1n-9 or 
18:2n-6 also suggested that the composition of chylomicron TG molecular species reflected 
that of the dietary oils, although individual molecular species were not reported [25].  In 
contrast, others have shown rearrangement of fatty acids in chylomicron TG compared to 
dietary TG [26] and that the molecular structure of ingested lipids containing 20:5n-3 and 
22:6n-3 did not influence the concentrations of these fatty acids in blood during the 
postprandial period [11].
The purpose of the present study was to investigate whether differences in the 
molecular species composition of TG in dietary oils influenced composition of plasma lipids 
during the postprandial period.  We compared the molecular species composition of two oils, a 
commercially prepared blended fish oil (BFO) with an oil from transgenic Camelina sativa 
(CSO) [27] that were the sole sources of 20:5n-3 and 22:6n-3 in each of two standardised test 
meals, with the molecular species composition of plasma TG during the postprandial period in 
healthy men and women.  We also investigated the impact of consuming these test meals on 
the concentrations of PC molecular species that contained 20:5n-3 and/or 22:6n-3. 
2.  Materials and Methods
2.1. Preparation of seed oil from transgenic C. sativa
Seed oil from transgenic C. sativa plants that produce 20:5n-3 and 22:6n-3 was prepared as 
described previously [12, 27].  Briefly, seeds were harvested from a homozygous T3 generation 
of transgenic C. sativa plants grown in an environmentally controlled containment glasshouse. 
After threshing, the oil was extracted by cold-pressing and solvent extraction, and then refined, 
bleached and deodorised (POS Bio-Sciences, Canada). 
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2.2. Ethics statement
Ethical approval for the study was granted by the South Central – Hampshire B Research 
Ethics Committee (REC reference 15/SC/0627).  The study is registered at ClinicalTrials.gov 
(Identifier: NCT03477045).  All participants provided written informed consent.
2.3. Human postprandial study
The data reported here were obtained from the analysis of samples collected as part of a 
postprandial crossover study that compared the incorporation into blood lipids of 20:5n-3 and 
22:6n-3 provided as either a commercially prepared BFO (Simply Timeless®, Seven Seas, 
Feltham, UK) or as CSO [12].  Details of the study design, including participant characteristics 
and inclusion criteria, are described elsewhere [12].  Briefly, healthy men and women aged 
between 18 to 30 years consumed one of two test breakfasts after fasting overnight for 
approximately 12 hours.  The test meals had similar nutrient contents and fatty acid 
compositions (details of the nutrient compositions and ingredients used are described 
elsewhere [12]).  Both test meals contained approximately 450 mg 20:5n-3 plus 22:6n-3 from 
either BFO (452 mg) or CSO (455mg). The total fat content of the test meals was BFO 49.5g 
and CSO 50.2g [12].  The amount of 20:5n-3 plus 22:6n-3 was based on current UK 
recommended daily intakes [28], while the total fat content of the test meals relfected 50% of 
the daily total fat intakes across the range reproted in European countries [29].  Thus the 
findings are potential relevance to the dietary habits of western populations.  The meals were 
consumed in random order at least 14 days apart. Venous blood samples were collected at 
baseline and at 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 7 and 8 hours after the meal.  No other food was 
consumed during this period, but water was consumed ad libitum.  Samples collected at 
baseline and at 1.5 and 6 hours after consuming the test meal were used for detailed analysis of 
lipid molecular species compositions.  Samples collected at 1.5 hours and 6 hours 
corresponded to peak 20:5n-3 and 22:6n-3 concentrations in TG and PC determined by gas 
chromatography [12].  Cells were removed from blood by centrifugation at 4oC [11] and the 
plasma fraction then stored at -80oC. 
2.4. Analysis of the fatty acid composition of blood lipids by gas chromatography
The fatty acid composition of plasma PC, TG and CE was measured by gas chromatography as 
described [11,30].  Briefly, dipentadecanoyl PC (100 μg), tripentadecanoin (100 μg) and CE 
heptadecanoate (100 μg) internal standards were added to 0.8 ml plasma (800 μl).  Plasma total 
lipids were extracted with chloroform/methanol (2:1 (v/v)) and individual lipid classes isolated 
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by solid phase extraction [12,30].  Fatty acids within purified lipid classes were converted to 
fatty acid methyl esters (FAME) by reaction with methanol containing 2% (v/v) sulphuric acid 
at 50 oC for 2 hours [30].  FAME were resolved on a BPX-70 fused silica capillary column (30 
m x 0.25 mm x 25 µm) using an Agilent 6890 gas chromatograph equipped with flame 
ionisation detection as described [12].  Fatty acid concentrations (µmol/ml) were calculated as 
described [30].
2.5. Analysis of the molecular species composition of the test oils and of blood lipids by mass 
spectrometry
Total lipids were extracted from plasma (200 μl) using methyl-tert-butyl-ether (MTBE) [31] 
and stored under nitrogen at -20 oC prior to analysis.  Briefly, MTBE (5 ml) was added to 
plasma (200 μl) and shaken at room temperature for 60 minutes.  Water (1.25 ml) was then 
added, the mixture vortex mixed and then centrifuged at 700 x g for 10 minutes.  The organic 
phase was collected and the aqueous phase then re-extracted with MTBE/methanol/water 
(10:3:2.5, v/v/v).  The organic phases were combined and dried under nitrogen at 35oC, 
dissolved in chloroform/methanol (9:1, v/v) and stored at -20oC.  TG and PC molecular species 
compositions were analysed by high resolution / accurate mass (HR/AM) lipidomics [32-34] 
using a Vanquish - Q Exactive Plus UPLC-MS/MS system (Thermo Fisher Scientific).
Plasma total lipids were diluted 1 in 100 in chloroform:methanol (1:1, v/v).  Internal 
standard, tripentadecanion (TG15:0/15:0/15:0; 0.857µM) and 1,2-dinervonoyl-sn-glycero-3-
phosphocholine (PC24:1/24:1; 0.857µM) were added and 20µl injected into the UPLC. Lipids 
were separated using an Accucore C18 (2.1 x 150 mm, 2.6 mm) column (Thermo Fisher 
Scientific) at 35oC with autosampler tray temperature at 10oC and flow rate 400 µl min -1. 
Mobile phase: A = 10 mM ammonium formate in 50% acetonitrile + 0.1% formic acid, B = 2 
mM ammonium formate in acetonitrile:propan-2-ol:water (10:88:2 v/v/v) + 0.02% formic acid.  
The elution gradient ran for 28 minutes from 35% B at start to 100% at 24 mins. The Thermo 
Q Exactive HESI II probe was in use probe position in C. Conditions were adjusted for 
separate positive and negative runs. Running samples in a single polarity facilitated 
identification of more molecular species. LC/MS full-scan at 140K resolution and data-
independent HCD MS2 experiments at 35,000 resolution were performed in positive and 
negative ion modes. The top 15 most abundant peaks from full scan with a mass resolution of 
140,000 for m/z 150-1200 were used for fragmentation.  Higher-energy collision dissociation 
with a 35,000 mass resolution was performed using an isolation window of 1 m/z, maximum 
integration time of 75 ms and dynamic exclusion window of 8 s. The stepped collision energy 
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was 25, 30, 40 eV replacing 25 with 30 eV negative ion mode. Sheath gas set to 60, Aux gas 
20, sweep gas 1, spray voltage 3.2 KV in positive ion mode with small adjustments in negative 
ion mode, capillary temperature 320oC and aux gas heater set to 370oC. The LipidSearch 4.2 
experimental workflow (Thermo Fisher Scientific) was used for lipid characterisation and 
potential lipid species were identified separately from positive or negative ion adducts. The 
data for each biological replicate were aligned within a chromatographic time window by 
combining the positive and negative ion annotations and merging these into a single lipid 
annotation.
Following normalisation to internal standards, peak areas corresponding to individual PC 
or TG molecular species that contained either 20:5n-3 and/or 22:6n-3 were expressed as a 
proportion of the total species containing 20:5n-3 and/or 22:6n-3 in either lipid class.  The 
proportion of each molecular species was then used to calculate its concentration from the 
concentrations of 20:5n-3 or 22:6n-3 measured by gas chromatography in either plasma PC or 
TG.  Molecular species that contained both 20:5n-3 and 22:6n-3 were present at low levels and 
were included with the 22:6n-3 -containing species.  It was not possible to assign fatty acids to 
specific glycerol sn positions of individual TG molecular species which are reported as 
combinations of fatty acids separated by an underscore [35].  Assignment of fatty acids to the 
sn-1 and sn-2 positions of PC was based on human plasma PC molecular species [36]. Raw  lipid 
molecular species composition data can be found at the EMBL-EBI MetaboLights database 
(http://www.ebi.ac.uk/metabolights)[37] with the identifier MTBLS1348.
2.6. Statistical analysis
Based on our previous findings [12], ten participants per group provided 85% power to detect a 
10% difference in peak postprandial 20:5n-3 or 22:6n-3 concentrations in plasma PC or TG 
with α = 5% in a two tailed analysis.  This level of statistical power was confirmed by 
retrospective power calculations.  Statistical comparisons were by ANOVA with sex and test 
oil as fixed factors, and time as a repeated measure with Tukey’s post hoc correction for 
multiple testing.  The distribution of the data was tested by analysis of residuals by the 
Shapiro–Wilk test.  According to Mauchly’s Test of Sphericity, the assumption of sphericity 
was not met for any of the molecular species measured and hence the Greenhouse-Geisser 
correction was applied to ANOVA analyses.  Estimated marginal means were calculated to 
allow comparison of the concentrations of individual molecular species between time points 
with adjustment for any interaction effects of participant sex or the type of test oil.  Post hoc 
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pairwise testing was by Tukey’s test.  All data are presented as mean ± SEM and statistical 
significance was assumed at P < 0.05.  
3. Results
3.1. Triacylglycerol molecular species compositions of the test oils
Two hundred and seventy-eight TG molecular species were identified in the test oils of 
which 40 contained 20:5n-3 in CSO and 40 in BFO (Table 1).  All the molecular species that 
contained 20:5n-3 were present in both oils.  However, the relative contribution of each species 
differed between the test oils.  The top three most abundant TG species accounted for 
approximately one quarter of all 20:5n-3 in both oils, but these molecular species differed 
between CSO (TG18:1_20:5_20:5  > TG18:0_20:5_20:5 > TG20:1_18:1_20:5; 26.4%) and 
BFO (TG16:0_18:1_20:5 > TG16:0_16:1_20:5 > TG16:0_20:5_20:5; 25.2%).  
TG18:4_18:4_20:5, TG18:3_17:1_20:5 and TG20:5_20:5_21:1 had the same position in the 
rank order of the proportions of TG molecular species in both CSO and BFO, but accounted for 
a greater proportion of 20:5n-3 in BFO compared with CSO (Table 1)
The same sixty-six TG molecular species that contained 22:6n-3 were identified in both 
CSO and BFO (Table 2).  TG18:0_16:0_22:6  > TG18:2_18:2_22:6 > TG16:0_18:1_22:6 were 
the most abundant 22:6n-3 -containing TG species in CSO, while the 22:6n-3 –containing 
species present in the greatest proportion in BFO were TG16:0_16:0_22:6 > 
TG16:0_18:1_22:6 > TG18:0_16:0_22:6.  The top three most abundant species accounted for 
approximately one third of all 22:6n-3 -containing species in each of the test oils (CSO, 30.6%; 
BFO 33.7%).  TG18:0_22:6_20:0, TG18:0_22:6_22:6, TG18:1_22:5_22:6, 
TG24:1_18:2_22:6, TG20:0_22:5_22:6, TG22:0_22:6_22:6 and TG24:0_20:3_22:6 had the 
same position in the rank order of 22:6n-3 –containing TG species but were present in greater 
proportions in BFO compared with CSO (Table 2).
Ten TG molecular species were identified in both test oils that contained 20:5n-3 and 
22:6n-3 (Table 3). TG16:0_20:5_22:6 accounted for approximately two thirds of 20:5n-3 and 
22:6n-3 species in both test oils.  TG20:5_22:6_22:6 and TG20:5_17:1_22:6 occupied the 
same rank position in both test oils, but accounted for a greater proportion of TG species in 
BFO compared to CSO. 
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3.2. Postprandial incorporation of 20:5n-3 and 22:6n-3 into plasma triacylglycerol molecular 
species
One hundred and eighty-two TG molecular species were identified in plasma collected 
at baseline and at 1.5 and 6 hours during the postprandial period.  Of these, ten molecular 
species contained 20:5n-3 (Fig. 1), three contained 20:5n-3 and 22:6n-3 and twenty-five 
contained 22:6n-3 (Fig. 2).  At baseline, TG16:0_18:2_20:5 was the most abundant 20:5n-3 –
containing species, TG16:0_20:5n-3_22:6n-3 was the most abundant species that contained 
both 20:5n-3 and 22:6n-3, and TG16:0_18:1_22:6 was the most abundant species that 
contained 22:6n-3 (Fig.s 1 - 3).  The concentration of TG16:0_20:5_22:6 was approximately 
10% of that of TG16:0_18:2_20:5 and 4% of TG16:0_18:1_22:6 (Fig.s 2,3).  There was a 
significant effect of time after the test meal was consumed on the concentrations of all TG 
molecular species that contained 20:5n-3, 22:6n-3 or 20:5n-3 and 22:6n-3 (Fig.s 1 - 3, Table 4). 
TG16:0_18:2_20:5, TG18:1_18:2_20:5 and TG20:5_18:2_18:2 showed the greatest overall 
increase in concentration compared to baseline (approximately 1 to 3 μmol/l), while the 
increase in concentration of all other 20:5n-3 and 22:6 –containing species was less than 0.2 
μmol/1 (Figure 2).  There was no significant single factor effect of the type of oil consumed on 
the concentrations of any 20:5n-3 or 22:6n-3 –containing molecular species during the 
postprandial period (Table 4).  There was a significant sex*time effect on the concentrations of 
TG16:0_18:2_20:5, TG20:5_18:2_18:2, TG16:1_18:2_20:5, TG18:1_20:5_20:5 and 
TG16:0_12:0_20:5 (Table 4).  There was a significant interactive effect of time*oil type*sex 
on TG18:1_20:5_20:5 concentration and a tendency towards a three-way interactive effect on 
TG16:0_18:2_20:5 and TG16:0_20:5_20:5 concentrations (Table 4).
There was a significant effect of time after the test meal was consumed on the 
concentrations of all TG molecular species that contained 22:6n-3 except TG18:1_22:6_22:6 
and TG18:2_22:6_22:6 (Table 4).  There was a significant sex*time interaction effect on the 
concentrations of TG18:2_18:2_22:6, TG16:0_18:3_22:6, TG16:1_18:2_22:6 and 
TG18:1_12:0_22:6, and a tendency towards an effect on TG18:1_18:2_22:6 (Table 4).  There 
was no significant singe factor effect of the type of oil consumed on the concentrations of any 
of the 22:6n-3 –containing molecular species (Table 4).  There were no 3-way interactive 
effects on the concentrations of any of the 22:6n-3-containing species that were measured.  The 
increments at 6 hours in the concentrations of 22:6n-3 –containing species tended to be less 
than for 20:5n-3 -containing species.
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There was no overlap in the rank order of TG molecular species containing 20:5n-3 
and/or 22:6n-3 in CSO and BFO (Tables 1 - 3) with that of plasma TG molecular species at 1.5 
hours after consuming the respective test oils, when the concentrations of recently secreted 
chylomicrons were highest [12] (Tables 1,2; Fig.s 1 - 3).  
3.3 Postprandial incorporation of 20:5n-3 and 22:6n-3 into plasma phosphatidylcholine 
molecular species
Fifty-four PC molecular species were identified in all plasma samples, of which four species 
contained 20:5n-3 and eight species contained 22:6n-3 (Fig. 4).   No species containing both 
20:5n-3 and 22:6n-3 were detected.  At baseline, PC16:0/20:5 and PC 18:0/20:5 were the most 
abundant 20:5n-3 -containing species.  The two sn-1 alkyl species that contained 20:5n-3, 
PC16:1Alkyl/20:5 and PC18:1Alkyl/20:5, were present in markedly lower concentrations than 
the equivalent ester-linked species (Fig. 4).  The major 22:6n-3 -containing PC species at 
baseline were, in order of decreasing concentration, PC16:0/22:6 > PC18:0/22:6 > PC18:1/22:6 
(Fig. 4).  The two alkyl species that contained 22:6n-3, PC16:1Alkyl/22:6 and 
PC18:0Alkyl/22:6 were present in lower concentrations that the ester-linked counterparts (Fig. 
4).  
There was a significant effect of time on the concentrations of all 20:5n-3 and 22:6n-3 –
containing PC species that were measured, except PC16:1Alkyl/22:6 (Table 5).  However, 
there were no interactive effects of sex or the type of oil consumed on any of the 20:5n-3 and 
22:6n-3 –containing PC species that were measured.  The change in PC16:0/20:5 concentration 
at 6 hours compared to baseline was between 2-fold and 3- fold greater than PC18:0/22:5. The 
increment in PC16:0/22:6 concentration at 6 hours was approximately 4-fold greater than for 
PC18:0/22:6.  
3.4 Incorporation of 20:5n-3 and 22:6n-3 into plasma cholesteryl esters
There was a significant effect of time (P < 0.0001) on the concentration of cholesteryl-16:0, 
but not on cholesteryl-20:5n-3 or cholesteryl-22:6n-3 concentrations (both P = 0.2) (Figure 4).
3.5 The time course of the postprandial incorporation of 20:5n-3 and 22:6n-3 into plasma 
phosphatidylcholine and triacylglycerol molecular species
Based on estimated marginal means, the concentration of PC16:0/20:5 was significantly 
greater at 1.5 hours than at baseline, and at 6 hours than 1.5 hours (Fig. 6A).  In contrast, 
PC18:0/20:5, PC16:0/22:6 and PC18:0/22:6 concentrations were greater at 1.5 hours than at 
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baseline, but did not change significantly between 1.5 hours and 6 hours (Figure 6 A,B).  Other 
minor PC 20:5 and 22:6 -containing molecular species that changed significantly over time 
also increased significantly at 1.5 hours compared to baseline, without further change.  
However, PC15:0/22:6 concentration was significantly lower at 1.5 hours and 6 hours 
compared to baseline.
The concentrations of seven out of ten 20:5n-3 -containing TG species that changed 
significantly over time were greater at 1.5 hours than at baseline, but did not differ further 
between 1.5 hours and 6 hours (Fig. 6C).  In contrast, TG16:0_20:5_20:5, TG18:3_18:2_20:5 
and TG20:5_18:2_20:5 concentrations were significantly lower at 1.5 hours than at baseline 
and did not change significantly between 1.5 hours and 6 hours.  The concentrations of twenty 
out of twenty-two 22:6n-3 -containing TG molecular species that changed significantly over 
time were greater at 1.5 hours than at baseline, but did not differ significantly between 1.5 
hours and 6 hours, while TG18:1_18:3_22:6, TG18:3_18:2_22:6 concentrations were 
significantly greater at 6 hours than at baseline or at 1.5 hours (Fig. 6D).
4. Discussion
The findings of this study show that the molecular composition of dietary fats had little, 
if any, relationship to the molecular composition of blood lipids during the postprandial period.  
Instead, these observations suggest that processes involved in the post-absorptive assembly of 
LCPUFA into TG and PC result in the complete rearrangement of the molecular composition 
of the ingested lipids in a manner that could influence the partitioning of these fatty acids 
between metabolic fates.  Moreover, these findings also showed that 20:5n-3 and 22:6n-3 are 
preferentially incorporated during the postprandial period into plasma PC compared to plasma 
TG or CE. 
CSO and BFO were composed of complex mixtures of TG molecular species.  Despite 
similarities in the overall proportions of 20:5n-3 and 22:6n-3 in CSO and BFO [12] and their 
combinations with other fatty acids in individual molecular species, the relative contribution of 
each molecular species to the overall 20:5n-3 and 22:6n-3 content differed markedly between 
the test oils.  For example, in CSO the most abundant 20:5n-3 and 22:6n-3 -containing TG 
species tended to also contain other unsaturated fatty acids. In BFO TG, 20:5n-3 and 22:6n-3 
had a greater tendency to be combined with saturated fatty acids than in CSO.  Previous 
analysis of the positional isomers of TG from an unspecified FO showed that almost all of the 
22:6n-3 and 44% of the 20:5n-3 were esterified at the sn-2 position [38].  In contrast, 20:5 and 
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22:6n-3 have been shown to be esterified predominately at the sn-1/3 position in CSO [27]. In 
rodents, ingested fatty acids that are esterified at the sn-1/3 position of TG have greater 
bioavailability than those at the sn-2 position due to the lower accessibility of the sn-2 position 
to pancreatic lipases [39, 40].  In contrast, the present results and our previous findings [12] 
show no significant differences between the test oils in the incorporation of 20:5n-3 and 22:6n-
3 into plasma total TG or individual plasma TG molecular species. Thus, any differences 
between the test oils in the distribution of 20:5n-3 and 22:6n-3 between TG sn positions have 
little influence their assimilation.
The differences in the TG molecular species compositions of the test oils were not 
reflected in the molecular composition of plasma TG during the postprandial period.  This 
suggests that the TG molecular species composition of ingested lipids has little, if any, 
influence on composition of 20:5n-3 and 22:6n-3 –containing TG molecular species that were 
secreted into the circulation during the postprandial period.  This is consistent with studies 
which showed that the structure of ingested lipids does not influence the postprandial 
incorporation of 20:5n-3 and 22:6n-3 into blood lipids [41, 42]. One interpretation is that the 
composition of meal-derived plasma TG containing 20:5n-3 and 22:6n-3 may be determined 
primarily by the selectivity of TG synthesis and could reflect, at least in part, the substrate 
specificity of acyl-CoA:diacylglycerol acyltransferases [43] in enterocytes and the 
incorporation of newly synthesised TG into chylomicrons.  However, the present findings do 
not exclude the possibility that the molecular species composition of TG from a meal could be 
modified by the activities of lipases in blood. 
It is assumed generally that chylomicron TG is the primary means by which PUFA, 
including 20:5n-3 and 22:6n-3, enter the circulation [1], although incorporation of 20:5n-3 and 
22:6n-3 into plasma PC may be quantitatively more important than TG for transport of dietary 
LCPUFA from enterocytes into the bloodstream [11, 12].  The present findings agree with this 
view and extend these observations by showing that 20:5n-3 and 22:6n-3 were incorporated 
into specific PC molecular species.  For example, the concentration of PC16:0/20:5, the 
predominant 20:5n-3 –containing PC species, at 1.5 hours was approximately 6.5 -fold greater 
than the most abundant 20:5n-3-containing TG species; TG16:0_18:2_20:5.  The concentration 
of PC16:0/22:6, the principal 22:6n-3 –containing PC species, was between 23 and 26 -fold 
greater than the most abundant 22:6n-3 -containing TG molecular species; TG16:0_18:1_22:6.  
Similarly, when participants consumed 20:5n-3 and 22:6n-3 in different molecular forms the 
incorporation during the postprandial period of 20:5n-3 and 22:6n-3 into plasma PC was 30% 
greater than into plasma TG, irrespective of the structure of the ingested LCPUFA [11].  One 
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interpretation is that 20:5n-3 and 22:6n-3 primarily enter the circulation on the surface of 
chylomicrons which could facilitate their availability for hydrolysis by lipoprotein lipase, 
although this preferentially cleaves PC at the sn-1 position [15].  One further implication is that 
studies that measure postprandial incorporation of 20:5n-3 and 22:6n-3 into plasma TG alone, 
and exclude the contribution of PC, may underestimate the assimilation of these LCPUFA.
The present findings and those reported previously [36] show that 20:5n-3 and 22:6-3 
are incorporated primarily into PC molecular species containing sn-1 16:0 compared to species 
containing sn-1 18:0.  LCAT preferentially transfers 16:0 from the sn-1 position of PC to 
cholesteryl esters when the sn-2 position is occupied by LCPUFA, in particular 22:6n-3 [16].  
For example, dietary supplementation for 6 weeks with 20:5n-3 and 22:6n-3 increased the 
proportion of sn-2 22:6n-3 in plasma PC, but also increased the proportion of 16:0, but not 
18:0, in plasma CE [44].  Thus, preferential partitioning of 20:5n-3 and 22:6n-3 into sn-1 16:0 
PC species may facilitate CE synthesis by LCAT during the postprandial period.  The present 
findings showed a rapid increase in cholesteryl- 16:0 during the early postprandial period, 
while there was no significant enrichment of plasma CE with either 20:5n-3 or 22:6n-3.  This 
suggests incorporation of meal derived LCPUFA into PC may be important for subsequent CE 
synthesis during the postprandial period.  Dietary supplementation with either fish oil for 21 
days [45] or an algal oil for 29 days [46] induced differential incorporation of 20:5n-3 and 
22:6n-3 into individual plasma PC molecular species, including those which showed the 
greatest increments during the postprandial period in the present study.  Together these 
findings suggest that plasma PC composition may also be determined by the specificity of PC 
synthesis, including the relative contributions of the Kennedy and acyl-remodelling 
mechanisms [47].  This agrees with previous studies that have shown that the molecular 
species composition of plasma PC is regulated physiologically rather than by diet.  For 
example, pregnancy in humans and rodents is associated with a differential increase in plasma 
and/ or hepatic PC16:0/22:6 concentration [48, 49], which in rodents involves decreased 
hepatic acyl remodelling of newly synthesised sn-1 16:0 to sn-1 18:0 PC species [49].
The greatest postprandial increments in 20:5n-3 and 22:6n-3 were in TG and PC 
molecular species that were present at the highest concentrations at baseline, namely 
TG16:0_18:2_20:5, TG16:0_18:1_22:6, PC16:0/20:5 and PC16:0/22:6.  Moreover, the rank 
order of the concentrations of individual 20:5n-3 and 22:6n-3 –containing TG and PC species 
at baseline was essentially maintained during the postprandial period.  Plasma TG and PC in 
baseline samples represents primarily VLDL derived from the liver.  Enterocytes can secrete 
VLDL-like particles in the fasting state, although these are likely to only be a minor 
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contributor to the total VLDL pool in humans [2].  However, PC and TG carrying fatty acids 
derived from a meal enter the circulation as chylomicrons [1].  If the specificity of TG and PC 
synthesis is a primary determinant of the composition of these lipids in plasma, then in order 
for the rank order of the molecular species in these lipids to be maintained throughout the 
fasting and postprandial periods the specificity of TG and PC synthesis would need to be 
similar in enterocytes and hepatocytes.  This view is supported in part by one study in rodents 
that suggested rapid postprandial equilibration of chylomicron phospholipid molecular species 
with those of endogenous lipoproteins [50].  Thus, the present findings may suggest that in 
human chylomicron TG and PC molecular species equilibrate rapidly with PC and TG carried 
by VLDL.  If so, one implication of these findings is that there is a metabolically favourable 
molecular species composition of lipoprotein TG and PC which is determined, at least in part, 
by the specificity of TG [51] and PC synthesis [47].  One alternative interpretation of the 
present findings, that does not exclude former suggestion, is that the persistence of specific 
molecular species throughout the postprandial period may represent those that are resistant to 
hydrolysis and so accumulate during the early postprandial period but are not turned over 
rapidly.  The presence in cell membranes of ‘pivot’ PC molecular species that are resistant to 
turnover has been proposed as a mechanism to control membrane structure and function [52].  
In the present context, it is possible that maintaining particular PC and TG molecular species 
compositions during the postprandial period may be important for conferring structural 
stability and function of lipoproteins.
The main limitations of the study were that individual lipoprotein classes were not 
isolated and so interpretation of the findings in terms of the metabolism of specific lipoproteins 
is speculative and the sn positions of the fatty acids in TG could not be determined.  
6.  Conclusions
In conclusion, these findings show that the molecular species composition of dietary lipids 
undergoes extensive rearrangement after absorption.  Whether this facilitates alignment with 
the substrate specificities of key enzymes that mediate postprandial hydrolysis of dietary fatty 
acids in TG-rich lipoproteins and/or reflects the persistence of specific molecular species that 
are important for lipoprotein structure or function remains to be determined.  These findings 
may have implications for understanding variation between individuals in the effectiveness of 
dietary interventions to increase 20:5n-3 and 22:6n-3 status and for identifying mechanisms by 
which specific fatty acids are supplied to individual tissues. 
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Fig. 1.  Concentrations of plasma triacylglycerol molecular species that contained 20:5n-3.  
Values are mean ± SEM concentrations of individual plasma TG molecular species that 
contained 20:5n-3 (n = 10/sex/oil type) in descending rank order of concentration at baseline.  
(A) and (B) Females, (C) and (D) males; (A) and (C) CSO, (B) and (D), BFO. Data were 
analysed by ANOVA with type of oil and sex as fixed factors and time as a repeated measure.  
Tukey’s correction for multiple comparisons were applied post hoc.  Different letters indicate 
means which differed significantly between time points.  The results of the statistical analyses 
are shown in Table 4.  The order of the fatty acids in each molecular species does not indicate 
the sn positions of the fatty acids.  
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Fig. 2.  Concentrations of plasma triacylglycerol molecular species that contained 22:6n-3 or 
22:6n-3 and 20:5n-3 in women.  
Values are mean ± SEM concentrations of individual plasma TG molecular species that 
contained 22:6n-3 or 22:6n-3 and 20:5n-3 (n = 10/oil type) in descending rank order of 
concentration at baseline.  (A) CSO and (B) BFO.  Data were analysed by ANOVA with type 
of oil and sex as fixed factors and time as a repeated measure.  Tukey’s correction for multiple 
comparisons were applied post hoc.  Different letters indicate means which differed 
significantly between time points.  The results of the statistical analyses are shown in Table 4.  
The order of the fatty acids in each molecular species does not indicate their sn positions.
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Fig. 3.  Concentrations of plasma triacylglycerol molecular species that contained 22:6n-3 or 
22:6n-3 and 20:5n-3 in men.  
Values are mean ± SEM concentrations of individual plasma TG molecular species that 
contained 22:6n-3 or 22:6n-3 and 20:5n-3 (n = 10/oil type) in descending rank order of 
concentration at baseline.  (A) CSO and (B) BFO.  Data were analysed by ANOVA with type 
of oil and sex as fixed factors and time as a repeated measure.  Tukey’s correction for multiple 
comparisons were applied post hoc.  Different letters indicate means which differed 
significantly between time points.  The results of the statistical analyses are shown in Table 4.  
The order of the fatty acids in each molecular species does not indicate their sn positions.
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Fig. 4.  Concentrations of plasma phosphatidylcholine molecular species that contained 20:5n-
3 or 22:6n-3. 
Values are mean ± SEM concentrations of individual plasma PC molecular species that 
contained 20:5n-3 or 22:6n-3 (n = 10/sex/oil type) in descending rank order of concentration at 
baseline.  Females (A) and (B), males (C) and (D); CSO (A) and (C) CSO, BFO (B) and (D).  
Data were analysed by ANOVA with type of oil and sex as fixed factors and time as a repeated 
measure.  Tukey’s correction for multiple comparisons were applied post hoc.  Different letters 
indicate means which differed significantly between time points.  The results of the statistical 
analyses are shown in Table 5.  The order of the fatty acids in each molecular species indicates 
their putative the sn positions of the fatty acids.
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Fig. 5.  Concentrations of cholesteryl-16:0, cholesteryl-20:5n-3 and cholesteryl-22:6n-3 in 
plasma during the postprandial period.
Values are mean ± SEM estimated marginal mean concentrations at baseline, 1.5 hours and 6 
hours corrected for time x sex and time x type of oil interactions.  (A) cholesteryl-16:0 (B) 
cholesteryl-20:5 or cholesteryl-22:6n-3.  *Values significantly different (P<0.05) from 
baseline.
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Fig. 6.  Concentrations of plasma phosphatidylcholine and triacylglycerol molecular species 
containing either 20:5n-3 or 22:6n-3 during the postprandial period.  
Values are mean ± SEM estimated marginal means for concentrations at baseline, 1.5 hours 
and 6 hours corrected for time x sex and time x oil interactions.  Concentrations of plasma 
(A,B) phosphatidylcholine and (C,D) triacylglycerol molecular species containing either (A,C) 
20:5n-3 or (B,D) 22:6n-3 (B,D).  Means that differed significantly (all P<0.001) by Tukey’s 
post hoc test are indicated by different letters.  Molecular species are shown in rank order of 
concentration at baseline. 
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Table 1 
Triacylglycerol composition of the test oils: molecular species containing 20:5n-3.
TG (% total 20:5n-3 –containing TG species)
CSO BFO
Molecular Species % Molecular Species %
18:1_20:5_20:5 10.58±0.07 16:0_18:1_20:5 10.32±0.14
18:0_20:5_20:5 8.42±0.09 16:0_16:1_20:5 8.56±0.03
20:1_18:1_20:5 7.36±0.06 16:0_20:5_20:5 6.34±0.04
20:0_18:2_20:5 6.92±0.05 18:1_20:5_20:5 6.30±0.05
18:0_16:0_20:5 6.55±0.10 16:0_16:0_20:5 6.11±0.02
16:0_18:1_20:5 6.53±0.10 18:3_18:2_20:5 6.01±0.03
16:0_20:4_20:5 6.11±0.04 20:1_18:1_20:5 5.27±0.04
20:5_18:2_22:5 5.56±0.03 20:0_18:2_20:5 5.11±0.04
18:3_20:5_22:5 5.47±0.05 18:3_18:3_20:5 4.73±0.03
20:5_18:2_20:5 5.47±0.06 16:1_16:1_20:5 4.25±0.03
16:0_20:5_20:5 4.52±0.04 18:0_16:0_20:5 4.21±0.02
18:3_18:2_20:5 4.03±0.03 18:4_16:0_20:5 4.18±0.01
18:3_20:5_20:5 3.34±0.28 20:5_18:2_22:5 3.57±0.03
16:0_18:3_20:5 3.16±0.05 18:0_20:5_20:5 2.96±0.01
18:3_18:3_20:5 3.11±0.03 20:0_20:3_20:5 2.85±0.02
16:0_16:0_20:5 2.35±0.02 16:0_18:3_20:5 2.77±0.03
20:0_20:3_20:5 2.30±0.03 16:0_20:4_20:5 2.72±0.01
16:0_16:1_20:5 2.06±0.02 20:5_18:2_20:5 2.52±0.01
20:5_20:5_22:5 1.79±0.04 16:0_14:0_20:5 1.95±0.09
18:4_16:0_20:5 1.67±0.02 20:5_20:5_20:5 1.23±0.05
16:0_20:5_24:0 1.32±0.04 18:3_20:5_22:5 1.07±0.01
18:4_18:3_20:5 1.03±0.05 18:4_20:5_20:5 0.98±0.05
20:5_20:5_20:5 0.98±0.06 18:3_20:5_20:5 0.90±0.05
16:1_16:1_20:5 0.70±0.01 18:4_18:3_20:5 0.86±0.02
18:4_20:5_20:5 0.52±0.03 17:0_18:2_20:5 0.85±0.04
18:4_18:4_20:5 0.15±0.01 18:4_18:4_20:5 0.61±0.01
18:3_20:5_23:0 0.05±0.00 20:5_17:1_20:5 0.47±0.01
17:0_18:2_20:5 0.05±0.00 20:5_20:5_22:5 0.47±0.02
18:3_20:5_23:1 0.03±0.00 18:3_17:1_20:5 0.37±0.01
15:0_18:3_20:5 0.03±0.00 16:0_20:5_24:0 0.34±0.01
18:3_17:1_20:5 0.02±0.01 15:0_18:3_20:5 0.31±0.00
20:5_17:1_20:5 0.02±0.00 18:3_20:5_23:0 0.20±0.00
15:0_20:5_20:5 0.02±0.00 17:0_18:1_20:5 0.12±0.01
24:1_20:5_22:1 0.01±0.00 20:5_17:1_22:5 0.10±0.02
18:3_17:1_20:5 0.01±0.01 15:0_20:5_20:5 0.05±0.00
16:0_14:0_20:5 0.01±0.00 18:3_17:1_20:5 0.04±0.00
18:3_17:1_20:5 0.01±0.00 18:3_17:1_20:5 0.03±0.00
16:0_20:5_23:0 0.01±0.00 24:1_20:5_22:1 0.02±0.00
18:0_20:5_23:0 0.01±0.00 18:3_20:5_23:1 0.02±0.00
20:5_20:5_21:1 0.00±0.00 20:5_20:5_21:1 0.01±0.00
Values are mean ± SEM proportions of individual TG molecular species that contained 20:5n-3 
(n = 11 technical replicates) in descending rank order of the proportion in the oils.  The order 
of fatty acids within each molecular species does not represent their sn positions.
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Table 2 
Triacylglycerol composition of the test oils: molecular species containing 22:6n-3.
TG (% total 22:6n-3 –containing TG species)
CSO BFO
Molecular Species % Molecular Species %
18:0_16:0_22:6 10.78±0.08 16:0_16:0_22:6 13.61±0.09
18:2_18:2_22:6 10.02±0.12 16:0_18:1_22:6 11.02±0.14
16:0_18:1_22:6 9.83±0.10 18:0_16:0_22:6 9.09±0.05
18:3_18:3_22:6 7.80±0.22 16:0_20:1_22:6 7.83±0.04
16:0_20:1_22:6 7.58±0.04 18:0_18:0_22:6 5.40±0.03
18:1_18:1_22:6 7.22±0.04 16:0_22:6_22:6 5.07±0.04
18:0_18:0_22:6 6.21±0.06 18:1_18:1_22:6 4.91±0.04
16:0_22:6_22:6 5.16±0.07 18:3_18:3_22:6 3.96±0.03
16:0_16:0_22:6 5.02±0.04 18:2_18:2_22:6 3.91±0.05
16:0_22:5_22:6 4.35±0.02 22:0_18:2_22:6 2.86±0.04
20:1_18:3_22:6 3.93±0.03 16:0_22:5_22:6 2.83±0.03
18:3_22:5_22:6 2.54±0.03 16:0_14:0_22:6 2.61±0.11
18:3_22:6_22:6 1.91±0.05 18:0_22:1_22:6 2.40±0.04
18:0_20:0_22:6 1.82±0.05 18:0_20:0_22:6 2.34±0.03
18:1_22:6_22:6 1.82±0.02 16:0_22:0_22:6 2.27±0.04
16:0_22:0_22:6 1.74±0.05 20:1_22:1_22:6 2.04±0.06
18:0_22:6_22:6 1.37±0.01 18:0_22:6_22:6 1.75±0.01
18:1_22:5_22:6 1.31±0.01 18:1_22:5_22:6 1.72±0.01
20:4_22:6_22:6 0.61±0.01 18:1_22:6_24:1 1.64±0.05
22:1_18:2_22:6 0.54±0.00 20:1_18:3_22:6 1.46±0.01
18:3_22:1_22:6 0.53±0.00 18:1_22:6_22:6 1.31±0.01
18:0_22:1_22:6 0.51±0.01 22:1_22:1_22:6 0.83±0.02
20:3_22:6_22:6 0.49±0.01 18:3_22:6_22:6 0.79±0.03
20:4_22:6_22:6 0.46±0.02 18:0_22:0_22:6 0.74±0.03
22:0_18:3_22:6 0.44±0.01 18:1_17:1_22:6 0.65±0.03
18:0_22:0_22:6 0.35±0.02 20:1_22:5_22:6 0.54±0.01
22:0_18:2_22:6 0.32±0.01 17:0_18:2_22:6 0.51±0.01
22:5_22:6_22:6 0.26±0.00 22:1_18:2_22:6 0.48±0.00
20:2_22:6_22:6 0.25±0.00 20:0_22:6_22:6 0.47±0.01
20:1_22:6_22:6 0.23±0.00 18:3_22:5_22:6 0.45±0.01
20:2_22:5_22:6 0.21±0.00 22:0_18:3_22:6 0.42±0.01
22:6_22:6_22:6 0.19±0.01 20:1_22:6_22:6 0.41±0.00
20:1_22:5_22:6 0.16±0.00 20:2_22:5_22:6 0.38±0.00
20:0_22:6_22:6 0.12±0.00 18:3_22:1_22:6 0.37±0.00
20:1_22:1_22:6 0.11±0.01 20:4_22:6_22:6 0.35±0.01
24:1_18:3_22:6 0.11±0.00 20:4_22:6_22:6 0.25±0.01
24:1_18:2_22:6 0.10±0.00 24:1_18:2_22:6 0.21±0.00
18:0_19:0_22:6 0.07±0.00 22:1_22:5_22:6 0.21±0.02
20:0_22:5_22:6 0.07±0.00 20:0_22:5_22:6 0.20±0.00
22:4_22:6_22:6 0.06±0.00 18:0_22:6_24:1 0.19±0.01
18:1_22:6_24:1 0.06±0.00 19:0_18:3_22:6 0.16±0.01
18:0_22:6_24:1 0.05±0.00 20:3_22:6_22:6 0.15±0.00
18:1_17:1_22:6 0.05±0.01 22:1_22:6_22:6 0.14±0.00
18:0_19:0_22:6 0.04±0.00 18:0_19:0_22:6 0.11±0.00
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19:0_18:3_22:6 0.03±0.01 24:1_18:3_22:6 0.11±0.00
22:0_22:6_22:6 0.03±0.00 22:0_22:6_22:6 0.10±0.00
18:0_22:6_24:0 0.02±0.00 15:0_18:2_22:6 0.10±0.01
17:0_18:2_22:6 0.02±0.01 22:6_22:6_22:6 0.09±0.00
22:1_22:5_22:6 0.02±0.00 20:2_22:6_22:6 0.08±0.00
18:2_22:6_23:1 0.02±0.00 17:0_22:5_22:6 0.07±0.00
15:0_18:2_22:6 0.02±0.00 24:1_20:3_22:6 0.05±0.00
18:0_22:6_23:1 0.02±0.00 22:5_22:6_22:6 0.05±0.01
24:1_20:4_22:6 0.02±0.00 18:0_22:6_23:1 0.05±0.00
24:1_22:6_22:6 0.01±0.00 18:0_19:0_22:6 0.04±0.00
19:1_22:6_22:6 0.01±0.00 17:0_22:6_22:6 0.04±0.00
24:1_20:3_22:6 0.01±0.00 22:2_22:6_22:6 0.03±0.00
22:1_22:6_22:6 0.01±0.00 22:4_22:6_22:6 0.03±0.00
22:1_22:1_22:6 0.01±0.00 24:1_22:6_22:6 0.03±0.00
22:2_22:6_22:6 0.01±0.00 24:1_20:4_22:6 0.02±0.00
22:4_22:6_22:6 0.01±0.00 18:2_22:6_23:1 0.02±0.00
17:0_22:5_22:6 0.01±0.00 18:0_22:6_23:0 0.02±0.00
16:0_14:0_22:6 0.01±0.00 18:0_22:6_24:0 0.01±0.00
18:0_22:6_23:0 0.01±0.00 19:1_22:6_22:6 0.00±0.00
24:0_20:3_22:6 0.004±0.000 24:0_20:3_22:6 0.004±0.000
17:0_22:6_22:6 0.004±0.000 20:0_22:6_24:0 0.002±0.000
20:0_22:6_24:0 0.003±0.000 24:0_22:6_22:6 0.001±0.000
Values are mean ± SEM proportions of individual TG molecular species that contained 22:6n-3 
(n = 11 technical replicates) in descending rank order of their proportions in the test oils.  The 
order of fatty acids within each molecular species does not represent their sn positions.
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Table 3
Triacylglycerol composition of the test oils: molecular species containing 20:5n-3 and 22:6n-3.
TG (% total 22:6n-3 -containing TG species)
CSO BFO
Molecular Species % Molecular Species %
16:0_20:5_22:6 56.38±0.36 16:0_20:5_22:6 60.98±0.86
18:3_20:5_22:6 19.53±0.09 20:1_20:5_22:6 11.51±0.09
20:5_20:4_22:6 12.11±0.07 20:5_20:5_22:6 9.22±0.41
20:1_20:5_22:6 7.03±0.07 18:3_20:5_22:6 7.88±0.20
20:5_20:5_22:6 4.73±0.29 20:5_20:4_22:6 6.37±0.13
20:5_22:6_22:6 0.61±0.03 20:5_22:6_22:6 3.14±0.18
19:1_20:5_22:6 0.16±0.00 15:0_20:5_22:6 0.53±0.03
24:0_20:5_22:6 0.04±0.00 19:1_20:5_22:6 0.30±0.01
15:0_20:5_22:6 0.03±0.00 24:0_20:5_22:6 0.05±0.00
20:5_17:1_22:6 0.01±0.00 20:5_17:1_22:6 0.02±0.00
Values are mean ± SEM proportions of individual DAG molecular species that contained 
20:5n-3 and 22:6n-3 (n = 11 technical replicates) in descending rank order of their proportions 




Results of statistical analysis of triacylglycerol molecular species concentrations during the 
postprandial period.
Data were analysed by ANOVA with type of oil and sex as fixed factors and time as a repeated 
measure.  Tukey’s correction for multiple comparisons were applied post hoc.  The order of 
fatty acids does not represent their sn positions.
Table 5
ANOVA
Time Sex*Time Oil*Time Oil*Time*Sex
Molecular species F, P F, P F, P F, P
Molecular species containing 20:5n-5
16:0_18:2_20:5 48.1, <0.0001 4.3, 0.02 0.15, 0.9 2.9, 0.06
18:1_18:2_20:5 33.9, <0.0001 1.4, 0.2 1.7, 0.2 1.7, 0.2
20:5_18:2_18:2 49.1, <0.0001 3.8, 0.04 1.7, 0.2 2.9, 0.07
14:0_18:2_20:5 64.6, <0.0001 4.7, 0.12 0.7, 0.5 1.8, 0.2
16:1_18:2_20:5 50.1, <0.0001 5.8, 0.005 0.1, 0.9 3.2, 0.46
16:0_20:5_20:5 68.7, <0.0001 3.5, 0.2 1.7, 0.2 3.2, 0.06
18:1_20:5_20:5 39.7, <0.0001 5.0, 0.01 0.9, 0.4 4.4, 0.02
18:3_18:2_20:5 20.6, <0.0001 3.1, 0.06 0.3, 0.7 1.7, 0.2
20:5_18:2_20:5 38.6, <0.0001 1.8, 0.2 0.2, 0.7 1.6, 0.2
16:0_12:0_20:5 26.7, <0.0001 3.9, 0.03 0.1, 0.9 0.6, 0.5
Molecular species containing 22:6n-3
16:0_18:1_22:6 25.2, <0.0001 1.0, 0.4 0.3, 0.8 2.6, 0.09
16:0_18:2_22:6 43.8, <0.0001 2.2, 0.1 0.2, 0.8 0.8, 0.5
18:1_18:1_22:6 32.1, <0.0001 1.4, 0.3 0.1, 0.9 2.4, 0.1
18:0_18:1_22:6 23.7, <0.0001 0.6, 0.5 1.1, 0.4 2.3, 0.1
18:1_18:2_22:6 38.3, <0.0001 3.2, 0.06 0.1, 0.9 1.6, 0.2
18:2_18:2_22:6 47.8, <0.0001 3.7, 0.04 0.1, 0.9 1.5, 0.2
16:0_18:3_22:6 57.7, <0.0001 4.6, 0.02 0.4, 0.6 2.0, 0.1
16:1_18:2_22:6 58.2, <0.0001 4.0, 0.03 0.5, 0.6 1.6, 0.2
18:1_20:4_22:6 32.0, <0.0001 1.3, 0.3 0.2, 0.7 2.2, 0.1
18:1_12:0_22:6 50.5, <0.0001 3.9, 0.03 0.7, 0.5 0.5, 0.6
16:0_22:5_22:6 23.6, <0.0001 1.0, 0.4 0.1, 0.8 2.0, 0.2
18:0_16:0_22:6 37.8 <0.0001 0.4, 0.6 0.06, 0.9 0.8, 0.4
18:1_18:3_22:6 16.8, <0.0001 0.7, 0.5 1.1, 0.3 1.1, 0.3
18:3_18:2_22:6 44.2, <0.0001 1.7, 0.2 0.4, 0.6 0.6, 0.4
18:0_20:4_22:6 10.5, <0.0001 1.6, 0.2 1.4, 0.3 2.0, 0.2
15:0_18:1_22:6 22.1, <0.0001 1.4, 0.3 0.1, 0.8 1.3, 0.3
16:0_22:6_22:6 10.7, <0.001 2.4, 0.1 0.4, 0.6 1.3, 0.3
16:0_12:0_22:6 37.7, <0.0001 1.4, 0.3 0.3, 0.7 0.2, 0.8
18:1_22:6_22:6 1.5, 0.2 0.6, 0.5 1.1, 0.3 1.6, 0.2
12:0_18:2_22:6 53.8, <0.0001 3.3, 0.05 1.0, 0.4 1.2, 0.3
15:0_18:2_22:6 7.4, 0.004 0.5, 0.6 1.3, 0.3 2.2, 0.1
18:2_22:6_22:6 2.68, 0.1 1.5, 0.2 2.4, 0.1 2.5, 0.1
Molecular species containing 20:5n-5 and 22:6n-3
16:0_20:5_22:6 45.2, <0.0001 2.3, 0.1 0.1, 0.9 2.0, 0.2
18:1_20:5_22:6 13.7, <0.0001 1.5, 0.2 0.8, 0.4 1.1, 0.3
20:5_18:2_22:6 15.1, <0.0001 2.6, 0.1 0.7, 0.1 2.0, 0.2
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Results of statistical analysis of phosphatidylcholine molecular species concentrations during 
the postprandial period.   
Data were analysed by ANOVA with type of oil and sex as fixed factors and time as a repeated 
measure.  Tukey’s correction for multiple comparisons were applied post hoc.  For plasma PC, 
the order of fatty acids indicates their sn positions.
ANOVA
Time Sex*Time Oil*Time Oil*Time*Sex
Molecular species F, P F, P F, P F, P
Molecular species containing 20:5n-5
16:0/20:5 67.5, <0.0001 1.9, 0.6 0.27, 0.2 0.52, 0.4
16:1A/20:5 6.6, 0.008 0.7, 0.5 1.0, 0.4 1.6, 0.2
18:0/20:5 28.7, <0.0001 2.6, 0.06 1.4, 0.3 0.5, 0.6
18:1A/20:5 3.3, 0.001 0.07, 0.4 0.4, 0.4 0.4, 0.6
Molecular species containing 22:6n-3
14:0/22:6 31.6, <0.0001 0.002, 0.9 0.87, 0.4 1.0, 0.3
15:0/22:6 23.5, < 0.0001 0.97, 0.4 0.6, 0.6 0.07, 0.9 
16:0/22:6 25.8, <0.0001 0.35, 0.7 1.0, 0.4 0.95, 0.4
16:1A/22:6 0.02, 0.9 0.04, 0.9 0.89, 0.4 0.67, 0.5
17:0/22:6 6.9, 0.005 0.61, 0.5 0.63, 0.5 0.88, 0.4
18:0/22:6 16.43, <0.0001 0.87, 0.4 0.9, 0.4 1.3, 0.3
18:0A/22:6 8.9, 0.001 0.022, 0.9 0.09,0.9 0.27, 0.7
18:1/22:6 2.5, <0.0001 0.18, 0.8 0.69, 0.5 0.95, 0.4
